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1. Introduction
  Wound healing, as a normal biological process in 
human body, is achieved through four precisely and 
highly programmed phases: hemostasis, inflammation, 
proliferation and remodeling. For successfully healing, all 
four phases must occur in the proper sequence that involves 
soluble mediators, blood cells, extracellular matrix, and 
parenchymal cells in a time frame[1]. Wounds that exhibit 
impaired healing, including delayed acute wounds and 
chronic wounds, generally have failed to progress through 
the normal stages of healing. Such wounds frequently enter 
a state of pathologic inflammation due to a postponed, 
incomplete, or uncoordinated healing process. Most chronic 
wounds are ulcers that are associated with ischemia, 
diabetes mellitus, venous stasis disease, or pressure[2].
  The Martynia annua (M. annua) Linn. (Family Martyniaccae), 
a glandular hairy annual herb and commonly known 
as Bichchhu, used in epilepsy and applied locally to 
tuberculosis glands of camel’s neck. The juice of leaves 
used as a gargle for sore throat, fruit in inflammation, leaf 
paste has beneficial effect when applied to wounds of 
domestic animal[3,4]. The root extract exhibited fungicide 
activity against Alternaria alternata (A. alternata) and 
Aspergillus niger (A. niger). Chemical examination of M. annua
Linn. plant revealed the presence of glycosides, tannins, 
carbohydrates, phenols, flavonoids and anthocyanins. 
Flowers contain cyanidin-3-galactoside whilst p-hydroxy 
benzoic acid, snapic acid, and gentisic acid are present 
in leaves and fruits respectively[5]. The leaves contain 
chlorogenic acid and seeds-fatty acids. The anti-
inflammatory activity of ethanol extract of Martynia diandra 
(M. diandra) Glox. was reported in both acute and sub-
acute inflammatory process[6]. In previous study we had 
reported the ethanol extract of M. annua Linn. leaves have 
wound healing potential in incision and excision wound 
models in rats[7]. The present study was aimed to evaluate 
wound healing potential of flavonoid fractions of M. annua 
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Linn. leaves in diabetic rats on the basis of preliminary 
study and folkloric information.
2. Material and method
2.1. Plant material 
  The leaves of M. annua Linn. were collected adjoining the 
campus of University, during month of September to October. 
The plant was identified (No. Bot/Her/267) in Department of 
Botany, Dr. H. S. Gour University Sagar, M. P. (INDIA). The 
plant material was dried in shade, powdered and sieved 
through 40-mesh size for further studies.
2.2. Extraction and isolation of flavonoids
  The powdered plant materials M. annua Linn. leaves 
(2 kg) were defatted with petroleum ether (60-80 曟)
and extracted with ethyl alcohol for 3-4 d. The dried ethyl 
alcohol extract was treated with chloroform repeatedly 
to obtained chloroform soluble fraction and chloroform 
insoluble fraction. The chloroform insoluble fraction was 
dissolved in methanol repeatedly to obtained methanol 
soluble fraction (5.7 g). The methanol soluble fraction (MAF) 
gives positive test for flavonoids.
  The methanol soluble fraction was subjected to separate 
different constituents by column chromatography. The 
stationary phase Silica (Merck, 60-120 mesh) bed was 
prepared in chloroform as mobile phase in the glass column 
(35 cm × 1.5 cm), the bed (final geometry 28 cm ×1.5 cm) 
was allowed to settle. A 2.0 g dry fraction sample was 
applied to the column and elution was carried out with 
chloroform, chloroform-methanol using gradient elution 
(90:10, 80:20, 70:30, and 60:40). The 5 mL of each relevant 
fraction was collected and TLC of each fraction was done 
with, toluene: chloroform: acetone (40:25:35) as solvent 
system. The relevant fractions (No. 64-69) were combined 
and further purified by recrystalization from methanol to 
give compound-1 (26.0 mg). The relevant fractions (No. 80-
86) were combined and purified by recrystalization from 
methanol to give compound-2 (20 mg). The compounds were 
further characterized by spectroscopic analysis and were 
identified by UV, infra red (IR), proton nuclear magnetic 
resonance (1H-NMR) and mass spectroscopy (MS). UV spectra 
were recorded on double beam Shimadzu UV-1700 model 
(Japan). IR spectra were recorded on a spectrum 100 FT-IR 
spectrometer supplied by PerkinElmer (Cape Town, South 
Africa) using KBr pellets. The 1H NMR data was recorded at a 
FT-NMR Cryo-magnet Spectrometer 400 MHz (Bruker) using 
CDCl3 as solvent with tetramethylsilane (TMS) as internal 
standard. EI-MS spectrum was scanned at 70 eV on a JEOL 
JMS600 instrument (Japan). 
2.3. Preparation of formulations
  The 5% w/w semisolid mass of M. annua fraction (MAF) 
was taken with simple ointment base B.P.[8]. The formulation 
of isolated compound-1 (luteolin) was prepared in two 
concentrations 0.2% and 0.5 % w/w by fusion method. 
Prepared formulations of luteolin and flavonoid fraction were 
referred as LUT and MAF ointment respectively which were 
subjected for dermal irritation study and wound healing 
activity in diabetic wound model. The marketed formulation, 
5% w/w Povidone Iodine Ointment USP (Zenith Drugs Pvt. 
Ltd, India) was took as a reference for comparison.
2.4. Experimental protocol
  Wistar albino rats (150-200 g) of either sex were selected 
for experiment. They were housed individually in well-
ventilated, temperature controlled (26依2) 曟 animal room for 
seven days of period prior experiment. The animals were 
given the standard commercial pellet rodent diet (Hindustan 
Lever Pvt Ltd, Bangalore, India) and water ad libitum. The 
procedures were reviewed and approved by the Institutional 
Animal Ethics Committee (Reg. No. 379/01/ab/CPCSEA). Six 
animals were taken in each group for study. The group I 
was referred as control group, given only simple ointment 
base while Group II, III and IV denoted as treatment groups 
were received topically MAF, LUT Ointment (0.2% w/w),
LUT Ointment (0.5% w/w) ointment respectively. The Group 
V received 5% w/w Povidone Iodine Ointment USP (Zenith 
Drugs Pvt Ltd, India) and served as reference group. 
They were applied twice daily and healing property was 
assessed in terms of physical, biochemical parameters and 
histopathological study.
2.5. Diabetic wound creation
  Wistar albino rats were made diabetic by being given a 
single injection of streptozotocin (STZ) prepared in Citrate 
buffer (0.1 M, pH 4.5) 50 mg/kg, i.p. after overnight fasting. 
Blood was taken from the orbital plexus, 24 h after the 
injection and glucose level was estimated using Glucometer. 
An excision wound was making on the rats showing elevated 
blood glucose (more than 250 mg/dL). Blood glucose level 
was estimate at the time of creation of the wounds and after 
treatment[9].
2.6. Dermal irritation study
  A primary skin irritation test was conducted on rats to 
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determine the potential of the ointment to produce an 
irritation after a single topical application. Three healthy 
young adult albino rats of either sex were fed commercial 
pellets diet and water ad libitum. Animals were acclimated 
to laboratories conditions for a period of 7 d prior to 
initiation of dosing. Animal room was kept at a constant 
temperature (19-24 曟).
  On the day before application, hairs of rats were removed 
from the dorsal and trunk area using a small animal 
clipper. On the day of dosing, but prior to application, the 
animals were examined for health and the skin checked 
for any abnormalities. No preexisting skin irritation was 
observed. Two to three grams of the ointment was applied 
to 6 cm2 intact area on each animal and caged. After 4 h 
of exposure to extract ointment, the test sites were gently 
cleaned from any residual substance. Individual evaluation 
of test dose was scored according to Draize Scoring System 
at approximately 1, 24, 48 and 72 h after removal of extract 
ointment[10]. The degree of irritancy was obtained by 
calculating the primary dermal irritation index (PDII).
PDII = 
(PDI for 1, 24, 48 and 72 h)
4
Primary dermal irritation (PDI毩) = Average erythema + 
Average edema
2.7. Percent wound contraction and epithelialization time
  The wound contraction of individual animal from control 
and treatment groups were measured in each two days 
interval using transparent graph sheet and rate of healing 
expressed as percentage contraction:
Percent wound contraction =
Healed area
Total area
伊100
2.8. Protein estimation
  On the post wounding days 18th the protein content of skin 
tissues were determined in  tissue lysate by treatment with 
a mixture of sodium tartrate, copper sulphate and sodium 
carbonate[11]. The mixture was left to stand for 10 min and 
then treated with Folin-Ciocalteau reagent that resulted in a 
bluish color in 20-30 min. The absorbance was taken at 650 
nm using Spectrophotometer.
2.9. Hydroxyproline measurement
  Wound t issues were analyzed on 18th day for 
hydroxyproline content, a basic constituent of collagen. 
Tissues were dried in a hot air oven at 60-70 曟 to constant 
weight and hydrolysed in 6N HCl at 130 曟 for 4 h in sealed 
tubes. The hydrolysate was neutralized to pH 7 then 
subjected to Chloramine-T oxidation for 20 min[12]. The 
reaction was terminated by addition of 0.4M perchloric acid 
and developed color with Ehlrich reagent at 60 曟 was read 
at 557 nm in UV (Shimadzu) Spectrophotometer.
2.10. Enzymatic and non-enzymatic antioxidant assay
  In diabetic wound, the small part of granuloma tissue 
was taken for antioxidant assay. The granuloma tissues 
were homogenized in phosphate buffer (pH 7.0) and 
centrifuged under cold condition. The clear supernatant 
was taken to assay of antioxidants level. Catalase was 
estimated following the breakdown of hydrogen peroxide[13]. 
Superoxide dismutase (SOD) was assayed[14] based on the 
inhibition of epinephrine autoxidation by the enzyme. 
Reduced glutathione (GSH) level was determined in 
tissues homogenates by immediately precipitation with 
0.1 mL of 25% TCA and the precipitate was removed after 
centrifugation[15]. Free-SH groups were assayed in a total
3 mL volume by the addition of 2 mL of 0.6 mM DTNB and 
0.9 mL 0.2 mM sodium phosphate buffer (pH 8.0) to 0.1 mL 
of the supernatant and the absorbance was read at 412 nm 
using UV spectrophotometer.
2.11. Histopathological study
  Animals were anaesthetized before taking skin sample 
using diethyl ether. On 18th day wound tissue specimen 
from control, treatment and reference group were collected 
and store in 10% formalin after that usual processing 6 毺m
thick sections were cut and stained with haematoxylin 
and eosin[16]. The histopathologic criteria were used in 
each animal for: epithelial proliferation, granuloma tissue 
formation and organization, newly formed capillaries. 
Sections were qualitatively assessed under light microscope 
and were observed fibroblast proliferation, collagen 
maturation, angiogenesis and epithelialization.
2.12. Statistical analysis
  Pharmacological data were represented as the mean依
S.D. for six rats and data were evaluated using the Tukey 
test. Values of P<0.01 were considered to be statistically 
significant.
Santram Lodhi et al./Asian Pacific Journal of Tropical Medicine (2013)253-259256
3. Results 
3.1. Separation of flavonoids
  Compound-1: It was yellow amorphous powder, melting 
point 325-328 曟. It is soluble in ethyl acetate, acetone, 
methanol and slightly soluble in hot water. The UV spectrum 
showed maxima (MeOH, 毸max) at 253, 268 and 348 nm, 
characteristic absorbance of polyphenolic compounds. 
The IR spectrum exhibited absorption bands[cm-1]:
3 420 (aromatic OH), 2 822-2 618 (C-H), 1 655 (C=O), 1 418 
(aromatic C=C), 1 265 and 1 029 (C-O), 874, 741 and 708 (tri 
substituted benzene ring). The 1H NMR spectrum exhibited 
a broad characteristic signal of aromatic hydroxyl groups 
at 9.43-10.84 (3H, 3’, 4’ and 7-H), 12.41 (1H, singlet, 5-H). 
The other protons signal at 7.40 (1H, double doublet, J = 
9.2, 2.1 Hz, 6’-H), 7.39 (1H, doublet, J = 2.2 Hz, 2’-H), 6.88 
(
1
H, doublet, J = 9.2 Hz, 5’-H), 6.60 (1H, singlet at 3-H), 6.43 
(
1
H, doublet, J = 2.2 Hz, 8-H) and 6.19 (1H, doublet, J = 6.2 
Hz, 6-H) were found. The EI-MS spectrum was showed 
molecular (C15H10O6) ion peak (m/z) at 286 (M+) and other 
fragments were found at 257, 137 and 120. By comparison of 
the spectral data with those of 2-(3, 4-Dihydroxyphenyl)-
5,7-dihydroxy-4-chromenone, compound-1 was identified 
as luteolin.
  Compound-2: It was yellow amorphous powder with 
melting point 335-338 曟 and soluble in ethyl acetate, 
acetone, methanol and slightly soluble in hot water. The
毸max was at 253, 265 and 335 nm, characteristic 
absorbance of polyphenolic compounds. The IR spectrum 
absorption bands at [cm-1]: 3 497-2 922 (OH), 2 618 (C-H), 1 
654 (C=O), 1 419 (aromatic rings), 1 265 and 1 028 (C-O), 877, 
741 and 708 (para-substitution of benzene ring). The 1H NMR 
spectrum exhibited a broad characteristic signal of aromatic 
hydroxyl groups at 9.41-10.82 (2H, 4’ and 7-H), 13.09 (1H, 
singlet, 5-H). The other protons signal at 7.93 (2H, double 
doublet, J = 8.1, 2’-H and 6’-H), 6.79 (1H, singlet, 3-H), 6.48 
(
1
H, doublet, J = 2.1, 8-H) and 6.19 (1H, doublet, J = 2.1, 6-H) 
were found. The EI-MS spectrum was showed molecular 
(C15H10O5) ion peak (m/z) at 270 (M+) and other fragments 
were found at 153 and 242. By comparison of the spectral 
data with those of 5, 7-dihydroxy-2-(4-methoxyphenyl) 
chromen-4-one, Compound-2 was identified as apigenin[17].
                                  
3.2. Dermal irritation study
  The dermal irrigation study showed at 1, 24, 48 and 72 h 
after the formulation application, very slight erythema was 
observed at 24 h in all formulations treatment group. The 
primary dermal irritation index for all formulations was 
found 0.25. No edema was observed in any treated group 
of rats. After 24 h, very slight erythema was observed in all 
treated groups of formulation.
3.3. Determination of percent wound contraction
  Wound contraction on different days is shown in Table 1 
(Figure 1). The treated group with 0.5 % w/w LUT ointment 
from 2 to 8 d, slightly increase in wound contraction was 
observed in comparison to control. From 10 to 18th days, in 
group treatment with 0.5 % w/w LUT ointment was observed 
significant (P<0.01) difference in percentage of wound 
Table 1
Effect of prepared formulations and reference ointment on percent wound contraction area of diabetic wound in rats.
Groups 
Post wounding days (Percent wound contraction) Epithelia-lization
 period2 4 6 8 10 12 14 16 18 20
Control (Base)   7.53依0.14 12.76依0.59 21.58依1.08 29.10依0.9 2 35.84依1.12 46.29依1.47 54.08依2.01 65.94依3.17   72.17依2.98 80.14依2.76 23
MAF ointment 12.87依0.59* 24.48依1.14* 32.57依1.55* 48.50依2.09* 59.64依2.14* 73.41依2.58 85.69依3.64* 94.52依3.17* 100.00依3.85* - 18
LUT ointment (0.2% w/w)   7.29依0.36ns 14.43依0.26ns 22.18依0.97ns 33.46依1.27ns 38.27依1.37ns 49.24依1.64ns 57.61依1.28ns 68.40依1.29ns   75.30依2.13ns 81.24依3.10ns 23
LUT ointment (0.5% w/w)   8.41依0.28ns 16.27依0.77 29.49依1.42 35.10依1.71 46.19依1.08* 58.20依1.52 67.27依2.10* 76.52依3.20*   87.61依3.17* 93.19依3.41* 21
Reference ointment 12.35依0.13 23.55依1.17 35.88依1.64 45.86依1.76 58.97依1.09* 69.48依2.18 79.61依2.17* 91.58依2.70* 100.00依3.27* - 18
n=6 albino rats per group, value represents Mean依S.D. *P< 0.01, when each treated group was compared with control group; nsP>0.05 (not 
significant).
Table 2
Effect of prepared formulations and reference ointment on different biochemical parameters of tissues from diabetic wound in rats.
Groups Hydroxyproline
(mg/g tissue)
Protein content
(mg/g tissue)
SOD
(毺g/50 mg tissue)
CAT
(毺mol/50 mg tissue)
GSH
(毺mol/50 mg tissue)
Control (Base) 23.29依1.19 31.76依1.15 13.54依0.24 16.27依0.42 10.93依0.53
MAF ointment  51.67依2.17*  61.28依2.67*  27.61依1.27*   29.52依1.37*   21.67依1.06*
LUT ointment (0.2% w/w)   20.84依0.34ns   27.28依1.29ns   15.43依0.63ns    20.07依0.39ns    14.34依0.64ns
LUT ointment (0.5% w/w) 39.62依1.28*  45.49依2.17*  18.70依0.87*   21.26依1.07*   17.26依0.70*
Reference ointment 50.43依1.64* 60.45依1.97*  25.15依1.26*   28.64依1.69*    23.53依1.02*
n=6 albino rats per group, value represents Mean依S.D. *P<0.01, when compared each treated group with control group; nsP>0.05 (not 
significant).
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contraction when compared to control group of animals. No 
significant difference was observed in group treated with 
0.2% w/w LUT ointment group of animals. On day 18th, the 
treatment with MAF ointment was showed 100% contraction 
but other group treated with 0.2% w/w LUT, 0.5% w/w LUT 
ointment and control group were showed (75.30依2.13),
(87.61依3.17) and (72.17依2.98) respectively. On day 18th no 
scars were observed in animal treated with MAF fraction and 
reference ointment, which was an indication for complete 
healing.
3.4. Hydroxyproline measurement
  The hydroxyproline content in wound tissue treated with 
different formulations and control group of animals are 
shown in Table 2. The hydroxyproline content in animals 
treated with MAF (51.67依2.17), 0.5% w/w LUT (39.62依1.28) 
and reference ointment (50.43依1.64) was found significantly 
(P<0.01) greater than control (23.29依1.19) group of animals. 
The treatment group of 0.2% w/w LUT ointment was not 
significantly increase in hydroxyproline content as compared 
to control group.
3.5. Protein estimation
  Over the 18th days treatment period, the protein content 
of wounds treatment groups with MAF (61.28依2.67), 0.5% 
w/w LUT (45.49依2.17) and reference ointment (60.45依1.97) 
was found significantly (P<0.01) increased. No significant 
increase was observed in treatment group of 0.2% w/w LUT 
and control group of animals (Table 2).
3.6. The enzymatic and non-enzymatic assay
  The enzymatic and non-enzymatic assay during wound 
healing in skin tissues are given in Table 2. The activity of 
tissue antioxidant components were increased in control 
group as well as in 0.2% w/w LUT ointment treated animals 
in comparison to reference group and other treated groups. 
Due to increased activity of antioxidants, their content was 
lower during healing process. Slightly increase in SOD, CAT 
and GSH was found in treatment groups of 0.5% w/w LUT, 
MAF ointment and reference ointment on 18th days.
3.7. Histopathological study
  Histopathological study was showed that well organized 
collagen fibers, increase in fibroblast cells and new blood 
vessels formation was observed (identified by the presence of 
erythrocytes in their lumen) in treated groups (MAF, LUT and 
reference ointment), other than control group . In the control 
group as well as 0.2% w/w LUT ointment group of animals 
was found a more marked proliferation of angioblasts and 
fibroblast with infilteration of large number of lymphocytes, 
microphages and a few neotrophils on 18th days (Figure 2).
In the group treated with MAF and reference ointment, 
formation of dense fibrous tissue and blood capillaries 
was observed on 18th days. The arrangement of capillaries 
was perpendicular to the fibrous tissue. Mature connective 
tissue and a few capillaries with a thick epidermal lining at 
the periphery of the wound were observed at 18th day. The 
group treated with 0.5 %w/w LUT ointment was found these 
changes were less pronounced and moderate degrees of 
inflammation were observed. 
DAYS 2 6                      10                   14                    18
Control
MAF
LUT (0.2 %)
LUT (0.5 %)
REFRENCE
Figure 1. Wound area of different groups treated with different 
formulations in diabetic wound method in rat.
A B C
D E
 
Figure 2. Photomicrograph of rat skin after post wounding with 
different formulation treatment in diabetic wound method. A: Control; 
B: MAF ointment; C: LUT ointment (0.2% w/w); D: LUT ointment 
(0.5% w/w); E: Reference ointment.
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4. Discussion
  Elevated blood glucose levels may cause endothelial 
damage with potential occlusion of capillary vessels as well 
as hyperglycemia-induced leukocyte dysfunction, decreased 
chemotaxis and phagocytosis resulting in impaired wound 
healing and increased risk of infection. Defective collagen 
metabolism in diabetics is also thought to be a factor in 
delayed wound healing. Hyperglycemia in animal studies is 
associated with increased collagenase and protease activity 
in rat gingiva and impaired vascular wound healing[18].
  The objective of present study was to evaluate healing 
property of flavonoid fraction of M. annua Linn. leaves and 
luteolin in diabetic rats. The phytochemical work concluded 
that ethanol extract of M. annua Linn. leaves contains 
flavonoids, which have been documented to have free radical 
scavenging effect and antibacterial activity[19]. Luteolin 
exerts a variety of pharmacological activities including 
anti-oxidant properties associated with its capacity to 
scavenge oxygen and potent anti-inflammatory. Luteolin is 
a flavone widely distributed in the plant kingdom, showed 
a concentration-dependent inhibitory activity in several 
models of oxidative stress[20-24]. The antioxidant potential 
of luteolin, is twice stronger than that of vitamin E and has 
strong scavenging properties for superoxide radicals. It is a 
potent physical quencher of singlet oxygen. Luteolin inhibits 
single strand break in DNA induced by singlet oxygen in a 
dose-dependent manner[25,26]. 
  Inflammation is a normal part of the wound healing 
process, and is important to the removal of contaminating 
microorganisms. In the absence of effective decontamination, 
however, inflammation may be prolonged as microbial 
clearance is incomplete. Both bacteria and endotoxins 
can lead to the prolonged elevation of pro-inflammatory 
cytokines (interleukin-1 and TNF-毩) and elongate the 
inflammatory phase. If this continues, the wound may enter 
a chronic state and fail to heal. This prolonged inflammation 
also leads to an increased level of matrix metalloproteases 
(MMPs), a family of proteases that can degrade the ECM[27,28]. 
Some swelling in a wound is inevitable and to a degree it is 
required for successful healing to occur, because if there is 
no inflammation then healing does not begin and if too little 
inflammation occurs then healing may be slow. However, 
if too much inflammation occurs, then the likelihood of 
excessive scar is produced. This inflammatory fluid, derived 
from the blood, is high in fibrinogen. Fibrinogen coagulates 
in the wound and in the surrounding tissues that are now 
fluid filled. The coagulated fibrin will later mature into a 
dense, binding scar. Excessive swelling, therefore, must 
not be permitted[29]. Thus luteolin and other flavonoids 
containing fraction may shortened the inflammation period, 
and contributes a resistance against the infections.
  Due to vascular disruption and high oxygen consumption 
by metabolically active cells, the microenvironment of 
the wound is quite hypoxic. Several systemic conditions, 
including old age and diabetes, can create impaired vascular 
flow, thus produced poor tissue oxygenation. In the context 
of healing, this overlay of poor perfusion creates a hypoxic 
wound[30]. The proper oxygen level is crucial for optimum 
wound healing. At initial stages, hypoxia is required to 
stimulate wound healing such as the release of growth 
factors and angiogenesis, while oxygen is needed to sustain 
the healing process[31]. In summary, the impaired healing 
that occurs in diabetic rats involves hypoxia, dysfunction 
in fibroblasts and epidermal cells, impaired angiogenesis, 
neovascularization and high levels of metalloproteases. 
An increase in the level of antioxidants was observed in 
granuloma tissues of diabetic wound. These antioxidants 
are known to quench the superoxide radical and thus 
prevent the damage of cells caused by free radicals. There 
is plenty of evidence to suggest that increased production of 
reactive oxygen species, lipid peroxidation and ineffective 
scavenging play a crucial role in various skin lesions and 
in modulation of fibroblast proliferation[32]. Cutaneous 
wounding causes a depression in the overall antioxidant 
status making it more vulnerable to oxygen radical attack[33]. 
All these finding indicate that in wound healing, antioxidants 
may play an important role. Significant increase was also 
observed in hydroxyproline content which was a reflection 
of increased collagen levels that was further supported 
by histopathological evidence. This indicated improved 
collagen maturation by increased cross-linking. Flavonoids 
have been shown to increase collagen synthesis, promote 
the cross-linking of collagen, decrease the degradation 
of soluble collagen, accelerate the conversion of soluble 
collagen to insoluble collagen, and inhibit the catabolism 
of soluble collagen. From a clinical point of view, collagen 
deposition in the wound is the most important phase of 
healing. Facilitating oxygen diffusion, increasing lymphatic 
drainage, diminishing oxygen free radical overproduction 
and increasing the collagen synthesis were together found 
to improve healing[34]. Collagen is a major protein of the 
extracellular matrix and is the component that ultimately 
contributes to wound strength. Breakdown of collagen 
liberates free hydroxyproline and its peptides. Measurement 
of this hydroxyproline therefore has been used as an index 
of collagen turnover. The increased hydroxyproline content 
of the excision wound has indicated faster collagen turnover 
leading to rapid wound healing. The differences in severity 
of vascular and cellular changes between the wounds 
treated with various medicaments might be due to different 
chemical constituents in medicaments.
  In conclusion, the observation and results obtained in present 
study indicated that flavonoid fraction of M. annua Linn. 
(MAF) possesses a definite healing action. The fraction, MAF 
was containing flavonoid, luteolin have also found healing 
promoter in concentration of 0.5% w/w. This is demonstrated 
by a significant increase in rate of wound contraction and 
by enhanced epithelization. Thus the present study reveals 
that one of the mechanisms of the improved healing by 
these plants may be due to its capacity to enhance tissue 
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antioxidant levels. These findings could justify, at least 
partially, the inclusion of this plant in the management of 
wound healing in folk medicine. This study also confirms 
the promising wound healing activity of luteolin in diabetic 
animals and deserve for detailed experiments on cellular 
level and clinical studies in future.
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